Beta-1,3-Glucan Phosphorylase Enzyme Synthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing beta-1,3-glucan are limited in efficiency and depend on beta-1,3-glucan synthase enzymes, and there is a need for alternative enzymatic processes that can produce beta-1,3-glucan with high purity and yield.

Innovation Solution

A reaction composition comprising water, alpha-G1P, an acceptor molecule, and a beta-1,3-glucan phosphorylase enzyme with an amino acid sequence at least 90% identical to specific SEQ IDs, which synthesizes beta-1,3-glucan, and a method involving heating and filtration to increase the concentration of dissolved beta-1,3-glucan, allowing for its precipitation and isolation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If beta-1,3-glucan synthase enzymes are used to produce beta-1,3-glucan, then the production can occur in vivo, but the efficiency and purity are limited

Engineering Contradiction:
Improveproduction efficiencyVSAvoidpurity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent uses phosphorylase enzymes as intermediary catalysts to convert alpha-glucose-1-phosphate and acceptor molecules into beta-1,3-glucan through a controlled in vitro phosphorolytic process. This intermediary enzymatic system bypasses the limitations of direct synthase-based production, enabling high efficiency and purity through optimized reaction conditions and enzyme specificity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces the biological in vivo synthesis system (beta-1,3-glucan synthase) with an in vitro biochemical system using phosphorylase enzymes. This substitution allows for better control over reaction parameters, substrate availability, and product purification, thereby improving both productivity and manufacturing precision.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Manufacturing precision

If alternative enzymatic processes are used to produce beta-1,3-glucan, then purity and yield can be improved, but the process complexity increases

Engineering Contradiction:
ImprovepurityVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent segments the beta-1,3-glucan production process into distinct stages: (1) enzyme preparation and activation, (2) controlled phosphorolytic synthesis using alpha-glucose-1-phosphate and acceptor molecules, (3) reaction condition optimization, and (4) product isolation. This segmentation allows each step to be independently optimized and controlled, improving purity without overwhelming complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs systematic parameter changes including pH adjustment, temperature control, substrate concentration optimization, and enzyme dosage control to maximize purity and yield. By carefully tuning these parameters, the process achieves high manufacturing precision while maintaining manageable complexity through standardized protocol development.

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If beta-1,3-glucan is produced with high concentration, then yield is improved, but isolation and purification become more difficult

Engineering Contradiction:
ImproveyieldVSAvoidisolation difficulty
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent performs preliminary actions during the synthesis phase by controlling molecular weight distribution, avoiding excessive branching, and maintaining soluble intermediate forms. These preliminary controls facilitate easier isolation and purification later, as the glucan maintains favorable physical properties for separation while achieving high yield.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent produces beta-1,3-glucan with controlled structural characteristics that replicate the desirable properties of natural glucans while simplifying isolation. By controlling the degree of polymerization and linkage patterns, the synthesized glucan mimics natural forms that are easier to purify, achieving high yield without compromising ease of manufacture.

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the efficient production of beta-1,3-glucan with high purity and yield, independent of beta-1,3-glucan synthase, and allows for the processing of beta-1,3-glucan to enhance its concentration in solutions, facilitating its isolation and use in various applications.

Implementation Method 1

a beta-1,3-glucan phosphorylase enzyme comprising an amino acid sequence that is at least 90% identical to SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, or SEQ ID NO:12, wherein the enzyme synthesizes beta-1,3-glucan

Methodology Applied
Scientific EffectEnzymatic catalysis: Enzyme

Implementation Method 2

heating the aqueous composition to at least about 75° C., thereby dissolving the beta-1,3-glucan in the aqueous composition

Methodology Applied
Scientific EffectThermal dissolution: Heating

Implementation Method 3

cooling the solution to a temperature at which the beta-1,3-glucan precipitates back to an insoluble state

Methodology Applied
Scientific EffectPrecipitation: Precipitation

Data Source

PatentUS20220195399A1Synthesis of glucan comprising beta-1,3 glycosidic linkages with phosphorylase enzymes
Publication Date: 2022.06.23 DANISCO US INC

AI summary

Reaction compositions are disclosed herein comprising at least water, alpha-glucose-1-phosphate (alpha-G1P), an acceptor molecule, and a beta-1,3-glucan phosphorylase enzyme. These reactions can synthesize oligosaccharides and polysaccharides with beta-1,3 glycosidic linkages. Further disclosed are methods of isolating beta-1,3-glucan.